In their first all-staff meeting since the start of the Trump administration, the interim leadership of the Centers for Disease Control and Prevention attempted to sidestep controversy and rally troops at the storied but demoralized agency on Tuesday.
Staff were told CDC director nominee Susan Monarez has begun meeting with senators in advance of a still-unscheduled Senate confirmation hearing. They were also informed the June meeting of the agency’s expert vaccine panel, the Advisory Committee on Immunization Practices, will be shorter than anticipated because the eight new members of the committee — 17 previous members were fired last week by health secretary Robert F. Kennedy Jr. — are not yet in a position to deal with all the agenda items.
There were no audible outbursts from staff during the tightly scripted hour-long meeting, which STAT listened to. But an email sent to agency personnel on Monday from CDC’s Office of Safety, Security, and Asset Management suggested there may have been fears the meeting could have been tense. “In advance of tomorrow’s CDC All-Staff meeting, we wanted to provide staff with the following reminders,” it began. Among the reminders was a list of items staff may not bring on CDC campuses that included firearms, mace or pepper sprays, or bladed tools. (STAT has viewed a copy of the email.)
The meeting aimed to boost morale and bring the agency together in the face of recent changes and challenges. The CDC, known for its expertise in infectious diseases and public health, has faced scrutiny and controversy in recent years, particularly during the COVID-19 pandemic.
The appointment of Susan Monarez as CDC director nominee has raised hopes for stability and leadership within the agency. Her meetings with senators indicate progress towards her confirmation, though a Senate hearing date has not yet been set.
The recent overhaul of the Advisory Committee on Immunization Practices, with the dismissal of 17 members and the addition of eight new members, has led to delays in the upcoming June meeting. The new members are still getting up to speed with the agenda items, causing the meeting to be shorter than expected.
Despite concerns about potential tensions at the meeting, staff remained composed and engaged during the hour-long session. The emphasis was on unity and moving forward as a team to tackle the public health challenges ahead.
As the CDC continues to navigate changes and transitions, the dedication and expertise of its staff remain critical in safeguarding public health and advancing research and vaccine development. With a new leadership on the horizon and a committed team, the CDC is poised to address infectious diseases and prepare for future outbreaks effectively.
